Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Antonella Riva MD

Antonella Riva MD

PhD student, Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy

Dr. Riva graduated in Italy in Medicine and Surgery from the University of Genoa with a thesis on the electro-clinical features of genetic epilepsy due to SCN1A mutation. She soon after won a Research fellowship at the IRCCS Istituto Giannina Gaslini, working with Prof. Pasquale Striano on genetic epilepsies and new therapeutic options. In 2020, she started a PhD in Genetics in the same Institute and is in her third year of training. The focus of her research is the genetic basis of epilepsies and the development of new therapeutic strategies. She is a member of the Italian League Against Epilepsy (LICE) and of the Italian society of paediatric neurology.


Dr. Riva has received honoraria from Kolfarma s.r.l, Jazz Pharmaceuticals, UCB Pharma, PTC Therapeutics and Proveca Pharma Ltd.